BlackRock, Inc. 13D and 13G filings for Pacira BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-19 2:40 pm Purchase | 2023-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 8,113,714 17.500% | 862,806 (+11.90%) | Filing |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 7,250,908 15.800% | 429,390 (+6.29%) | Filing |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 6,821,518 15.300% | 0 (Unchanged) | Filing |
| 2022-01-26 09:16 am Sale | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 6,821,518 15.300% | -278,329 (-3.92%) | Filing |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 7,099,847 16.300% | 95,348 (+1.36%) | Filing |
| 2020-02-10 07:32 am Purchase | 2019-12-31 | 13G | Pacira BioSciences, Inc. PCRX | BlackRock Inc. BLK | 7,004,499 16.800% | 245,550 (+3.63%) | Filing |